New cholera vaccines
- 1 April 1989
- Vol. 7 (2) , 94-96
- https://doi.org/10.1016/0264-410x(89)90042-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.Proceedings of the National Academy of Sciences, 1989
- SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgRThe Lancet, 1988
- Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field TrialThe Journal of Infectious Diseases, 1988
- IMPACT OF B SUBUNIT KILLED WHOLE-CELL AND KILLED WHOLE-CELL-ONLY ORAL VACCINES AGAINST CHOLERA UPON TREATED DIARRHOEAL ILLNESS AND MORTALITY IN AN AREA ENDEMIC FOR CHOLERAThe Lancet, 1988
- FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESHThe Lancet, 1986
- Mucosal Antitoxic and Antibacterial Immunity after Cholera Disease and after Immunization with a Combined B Subunit-Whole Cell VaccineThe Journal of Infectious Diseases, 1984
- Actions of cholera toxin and the prevention and treatment of choleraNature, 1981